2026 Journal Metrics Score
5.7
Updated August 2026 · 2-year citation average from OpenAlex data
The Journal Metrics Score is the two-year mean citedness of a journal, computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works. Quartiles rank journals within each OpenAlex subfield by score. Data source: OpenAlex (CC0).
| Category | Quartile |
|---|---|
| Biomaterials | Q2 |
| Pharmaceutical Science | Q1 |
| Molecular Biology | Q1 |
RSC Pharmaceutics's 2026 Journal Metrics Score is 5.7, updated August 2026 from OpenAlex citation data. The journal is ranked Q1 in this Journal Metrics record.
Use this record to check the journal title, ISSN, subfield quartile, CAS block, publisher details, and similar journals before comparing publication venues.
If you searched for RSC Pharmaceutics metrics, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.
This page is designed for exact-title searches such as RSC Pharmaceutics journal metrics. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.
For high-stakes submission decisions, verify the title against the publisher record, the journal's open catalog record (View on OpenAlex), and the context in our methodology. Treat the subfield quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.
Ranked #21 in Pharmacology by Journal Metrics Score and #21 among Q1 Pharmacology journals. This context helps compare RSC Pharmaceutics against journals publishing in the same field.
Published 333 papers across the last 4 recorded years with a current Journal Metrics Score of 5.7.
See if your manuscript fits this journal's recent focus before you commit to a shortlist.